643 related articles for article (PubMed ID: 26561593)
1. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.
Gallo S; Sala V; Gatti S; Crepaldi T
Clin Sci (Lond); 2015 Dec; 129(12):1173-93. PubMed ID: 26561593
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
Wang Y; Ahmad N; Wani MA; Ashraf M
J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
[TBL] [Abstract][Full Text] [Related]
3. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats.
Ueda H; Nakamura T; Matsumoto K; Sawa Y; Matsuda H; Nakamura T
Cardiovasc Res; 2001 Jul; 51(1):41-50. PubMed ID: 11399246
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells.
Sulpice E; Ding S; Muscatelli-Groux B; Bergé M; Han ZC; Plouet J; Tobelem G; Merkulova-Rainon T
Biol Cell; 2009 Sep; 101(9):525-39. PubMed ID: 19281453
[TBL] [Abstract][Full Text] [Related]
5. Necroptosis Induced by Ad-HGF Activates Endogenous C-Kit+ Cardiac Stem Cells and Promotes Cardiomyocyte Proliferation and Angiogenesis in the Infarcted Aged Heart.
Liu J; Wu P; Wang H; Wang Y; Du Y; Cheng W; Xu Z; Zhou N; Wang L; Yang Z
Cell Physiol Biochem; 2016; 40(5):847-860. PubMed ID: 27941320
[TBL] [Abstract][Full Text] [Related]
6. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor in physiology and infectious diseases.
Imamura R; Matsumoto K
Cytokine; 2017 Oct; 98():97-106. PubMed ID: 28094206
[TBL] [Abstract][Full Text] [Related]
9. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
Moransard M; Sawitzky M; Fontana A; Suter T
Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340
[TBL] [Abstract][Full Text] [Related]
10. Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells.
Rahman S; Patel Y; Murray J; Patel KV; Sumathipala R; Sobel M; Wijelath ES
BMC Cell Biol; 2005 Feb; 6(1):8. PubMed ID: 15717924
[TBL] [Abstract][Full Text] [Related]
11. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.
Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS
Carcinogenesis; 2014 Aug; 35(8):1891-900. PubMed ID: 24876152
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.
Liu Y
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F7-16. PubMed ID: 15180923
[TBL] [Abstract][Full Text] [Related]
13. Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.
Sonnenberg SB; Rane AA; Liu CJ; Rao N; Agmon G; Suarez S; Wang R; Munoz A; Bajaj V; Zhang S; Braden R; Schup-Magoffin PJ; Kwan OL; DeMaria AN; Cochran JR; Christman KL
Biomaterials; 2015 Mar; 45():56-63. PubMed ID: 25662495
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor and Met in drug discovery.
Sakai K; Aoki S; Matsumoto K
J Biochem; 2015 May; 157(5):271-84. PubMed ID: 25770121
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
Mou S; Wang Q; Shi B; Gu L; Ni Z
Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
[TBL] [Abstract][Full Text] [Related]
16. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts.
Nakamura T; Matsumoto K; Mizuno S; Sawa Y; Matsuda H; Nakamura T
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2131-9. PubMed ID: 15840903
[TBL] [Abstract][Full Text] [Related]
18. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
19. HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model.
Suárez-Causado A; Caballero-Díaz D; Bertrán E; Roncero C; Addante A; García-Álvaro M; Fernández M; Herrera B; Porras A; Fabregat I; Sánchez A
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2453-63. PubMed ID: 26001768
[TBL] [Abstract][Full Text] [Related]
20. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
Day RM; Cioce V; Breckenridge D; Castagnino P; Bottaro DP
Oncogene; 1999 Jun; 18(22):3399-406. PubMed ID: 10362361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
